MicroRNAs as novel regulators of neuroinflammation

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Ksiazek Winiarek, Dominika Justyna ^a   Kacperska, Magdalena Justyna ^a   Glabinski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 124; MICRORNA 146A; MICRORNA 155; MICRORNA 182; MICRORNA 20A; MICRORNA 31; UNTRANSLATED RNA;

ASTROCYTE; B LYMPHOCYTE; BIOGENESIS; CELL DIFFERENTIATION; DENDRITIC CELL; ENDOTHELIUM CELL; GRANULOCYTE; HUMAN; MACROPHAGE; MICROGLIA; MONOCYTE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; APOPTOSIS; AUTOIMMUNITY; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; GENETICS; HUMAN GENOME; INFLAMMATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; GENOME, HUMAN; HUMANS; INFLAMMATION; MICRORNAS; MULTIPLE SCLEROSIS; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION;

EID: 84881454133     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/172351     Document Type: Review

References (139)

1. Barker C. F., Billingham R. E., Immunologically priviledged sites. Advances in Immunology 1977 25 1 54
2. Galea I., Bechmann I., Perry V. H., What is immune privilege (not)? Trends in Immunology 2007 28 1 12 18 2-s2.0-33845628839 10.1016/j.it.2006.11.004 (Pubitemid 44960159)
3. Engelhardt B., Coisne C., Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids and Barriers of the CNS 2011 8 1 1 9 2-s2.0-80051762728 10.1186/2045-8118-8-4
4. Xu H., Manivannan A., Liversidge J., Sharp P. F., Forrester J. V., Crane I. J., Requirements for passage of T lymphocytes across non-inflamed retinal microvessels. Journal of Neuroimmunology 2003 142 1-2 47 57 2-s2.0-0242476427 10.1016/S0165-5728(03)00258-3 (Pubitemid 38368587)
5. Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J., Structure and function of the blood-brain barrier. Neurobiology of Disease 2010 37 1 13 25 2-s2.0-70449529433 10.1016/j.nbd.2009.07.030
6. Owens T., Bechmann I., Engelhardt B., Perivascular spaces and the two steps to neuroinflammation. Journal of Neuropathology and Experimental Neurology 2008 67 12 1113 1121 2-s2.0-58149402415 10.1097/NEN.0b013e31818f9ca8
7. Engelhardt B., Ransohoff R. M., The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends in Immunology 2005 26 9 485 495 2-s2.0-23744475685 10.1016/j.it.2005.07.004 (Pubitemid 41139258)
8. Engelhardt B., Sorokin L., The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Seminars in Immunopathology 2009 31 4 497 511 2-s2.0-73449115641 10.1007/s00281-009-0177-0
9. Keane R. W., Hickey W. F., Immunology of the Nervous System 1997 New York, NY, USA Oxford University Press
10. Wilson E. H., Weninger W., Hunter C. A., Trafficking of immune cells in the central nervous system. Journal of Clinical Investigation 2010 120 5 1368 1379 2-s2.0-77951837763 10.1172/JCI41911
11. Bechmann I., Failed central nervous system regeneration: a downside of immune privilege? NeuroMolecular Medicine 2005 7 3 217 228 2-s2.0-27144432088 10.1385/NMM:7:3:217 (Pubitemid 41507145)
12. Gimenez M. A., Sim J., Archambault A. S., Klein R. S., Russell J. H., A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. American Journal of Pathology 2006 168 4 1200 1209 2-s2.0-33645454762 10.2353/ajpath.2006.050332
13. Perry V. H., A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. Journal of Neuroimmunology 1998 90 2 113 121 2-s2.0-0345294457 10.1016/S0165-5728(98)00145-3 (Pubitemid 28511475)
14. Sawcer S., Hellenthal G. M G., International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011 476 7359 214 219
15. Ebers G. C., Environmental factors and multiple sclerosis. The Lancet Neurology 2008 7 3 268 277 2-s2.0-38949107656 10.1016/S1474-4422(08)70042-5 (Pubitemid 351222732)
16. Compston A., Coles A., Multiple sclerosis. The Lancet 2008 372 9648 1502 1517 2-s2.0-54149084585 10.1016/S0140-6736(08)61620-7
17. El-Behi M., Rostami A., Ciric B., Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology 2010 5 2 189 197 2-s2.0-77954563548 10.1007/s11481-009-9188-9
18. Hafler D. A., Multiple sclerosis. Journal of Clinical Investigation 2004 113 6 788 794 (Pubitemid 38544133)
19. Bettelli E., Korn T., Oukka M., Kuchroo V. K., Induction and effector functions of TH17 cells. Nature 2008 453 7198 1051 1057 2-s2.0-45749101727 10.1038/nature07036 (Pubitemid 351871737)
20. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E., Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009 132 12 3329 3341 2-s2.0-72649089874 10.1093/brain/awp289
21. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., Sallusto F., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nature Immunology 2009 10 5 514 523 2-s2.0-65249175159 10.1038/ni.1716
22. + T helper cells. Cell 2006 126 6 1121 1133 2-s2.0-33748588423 10.1016/j.cell.2006.07.035 (Pubitemid 44380299)
23. Vojdani A., Lambert J., The role of th17 in neuroimmune disorders: a target for cam therapy. Part I. Evidence-Based Complementary and Alternative Medicine 2011 2011 8 2-s2.0-80052770325 10.1093/ecam/nep062 927294
24. Yong V. W., Power C., Forsyth P., Edwards D. R., Metalloproteinases in biology and pathology of the nervous system. Nature Reviews Neuroscience 2001 2 7 502 511 2-s2.0-0035405886 10.1038/35081571 (Pubitemid 33676585)
25. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. Journal of Immunology 2006 177 1 566 573 2-s2.0-33745321276 (Pubitemid 43939170)
26. Lafaille J. J., Keere F. V., Hsu A. L., Baron J. L., Haas W., Raine C. S., Tonegawa S., Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. Journal of Experimental Medicine 1997 186 2 307 312 2-s2.0-0030739650 10.1084/jem.186.2.307 (Pubitemid 27328031)
27. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G. G., Chou Y. K., Bourdette D., Ziegler S. F., Offner H., Vandenbark A. A., Decreased FOXP3 levels in multiple sclerosis patients. Journal of Neuroscience Research 2005 81 1 45 52 2-s2.0-23744515175 10.1002/jnr.20522 (Pubitemid 41139109)
28. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. Journal of Experimental Medicine 2000 192 3 393 404 2-s2.0-0034618094 10.1084/jem.192.3.393 (Pubitemid 30629164)
29. Lo D., Feng L., Li L., Integrating innate and adaptive immunity in the whole animal. Immunological Reviews 1999 169 1 225 239 (Pubitemid 29338735)
30. Stoll G., Jander S., Schroeter M., Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Advances in Experimental Medicine and Biology 2002 513 87 113 2-s2.0-0036935538 (Pubitemid 36332404)
31. Medzhitov R., Janeway C. A. Jr., Innate immune recognition and control of adaptive immune responses. Seminars in Immunology 1998 10 5 351 353 2-s2.0-0032191163 10.1006/smim.1998.0136 (Pubitemid 28499548)
32. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., Brück W., Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002 125 10 2202 2212 2-s2.0-0036788406
33. Frischer J. M., Bramow S., Dal-Bianco A., Lucchinetti C. F., Rauschka H., Schmidbauer M., Laursen H., Sorensen P. S., Lassmann H., The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009 132 5 1175 1189 2-s2.0-66549130329 10.1093/brain/awp070
34. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., Sommer N., Hartung H.-P., Hemmer B., Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005 128 7 1667 1676 2-s2.0-21944448962 10.1093/brain/awh486 (Pubitemid 41373685)
35. Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., Dilitz E., Deisenhammer F., Reindl M., Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. The New England Journal of Medicine 2003 349 2 139 145 2-s2.0-0038790058 10.1056/NEJMoa022328 (Pubitemid 36818783)
36. Gaertner S., De Graaf K. L., Greve B., Weissert R., Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis. Neurology 2004 63 12 2381 2383 2-s2.0-11144342815 (Pubitemid 40024355)
37. Ponomarev E. D., Shriver L. P., Maresz K., Dittel B. N., Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. Journal of Neuroscience Research 2005 81 3 374 389 2-s2.0-25444484079 10.1002/jnr.20488 (Pubitemid 41359292)
38. Lynch M. A., The multifaceted profile of activated microglia. Molecular Neurobiology 2009 40 2 139 156 2-s2.0-73049110767 10.1007/s12035-009-8077-9
39. Kaushik D. K., Gupta M., Das S., Basu A., Kruppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. Journal of Neuroinflammation 2010 7, article 68 2-s2.0-77957922334 10.1186/1742-2094-7-68
40. Graeber M. B., Streit W. J., Microglia: biology and pathology. Acta Neuropathologica 2010 119 1 89 105 2-s2.0-77649184973 10.1007/s00401-009-0622-0
41. Carpentier P. A., Duncan D. S., Miller S. D., Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain, Behavior, and Immunity 2008 22 2 140 147 2-s2.0-37349032870 10.1016/j.bbi.2007.08.011 (Pubitemid 350299811)
42. Lee S. C., Cosenza M. A., Si Q., Rivieccio M., Brosnan C. F., Ransohoff R. M., Benveniste E. N., The CNS: cells, tissues and reactions to insult. Cytokines and the CNS 2005 Boca Raton, Fla, USA CRC Press
43. Slavin A., Kelly-Modis L., Labadia M., Ryan K., Brown M. L., Pathogenic mechanisms and experimental models of multiple sclerosis. Autoimmunity 2010 43 7 504 513 2-s2.0-77958006059 10.3109/08916931003674733
44. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
45. Heppner F. L., Greter M., Marino D., Falsig J., Raivich G., Hövelmeyer N., Waisman A., Rülicke T., Prinz M., Priller J., Becher B., Aguzzi A., Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nature Medicine 2005 11 2 146 152 2-s2.0-20044376483 10.1038/nm1177 (Pubitemid 40321349)
46. Marta M., Meier U. C., Lobell A., Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmunity Reviews 2009 8 6 506 509 2-s2.0-65549086460 10.1016/j.autrev.2009.01.006
47. Fernández M., Montalban X., Comabella M., Orchestrating innate immune responses in multiple sclerosis: molecular players. Journal of Neuroimmunology 2010 225 1-2 5 12 2-s2.0-77955664480 10.1016/j.jneuroim.2010.05. 014
48. Gandhi R., Laroni A., Weiner H. L., Role of the innate immune system in the pathogenesis of multiple sclerosis. Journal of Neuroimmunology 2010 221 1-2 7 14 2-s2.0-77951214891 10.1016/j.jneuroim.2009.10.015
49. Aberdam D., Candi E., Knight R. A., Melino G., miRNAs, "stemness" and skin. Trends in Biochemical Sciences 2008 33 12 583 591 2-s2.0-56449129371 10.1016/j.tibs.2008.09.002
50. Saini H. K., Griffiths-Jones S., Enright A. J., Genomic analysis of human microRNA transcripts. Proceedings of the National Academy of Sciences of the United States of America 2007 104 45 17719 17724 2-s2.0-36749026287 10.1073/pnas.0703890104 (Pubitemid 350210901)
51. Lian J., Zhang X., Tian H., Liang N., Wang Y., Liang C., Li X., Sun F., Altered microRNA expression in patients with non-obstructive azoospermia. Reproductive Biology and Endocrinology 2009 7, article 13 2-s2.0-61649128555 10.1186/1477-7827-7-13
52. Kim V. N., Han J., Siomi M. C., Biogenesis of small RNAs in animals. Nature Reviews Molecular Cell Biology 2009 10 2 126 139 2-s2.0-58849112575 10.1038/nrm2632
53. Borchert G. M., Lanier W., Davidson B. L., RNA polymerase III transcribes human microRNAs. Nature Structural and Molecular Biology 2006 13 12 1097 1101 2-s2.0-33845370280 10.1038/nsmb1167 (Pubitemid 44885920)
54. Gregory R. I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R., The Microprocessor complex mediates the genesis of microRNAs. Nature 2004 432 7014 235 240 2-s2.0-9144225636 10.1038/nature03120 (Pubitemid 39545855)
55. Takeda A., Iwasaki S., Watanabe T., Utsumi M., Watanabe Y., The mechanism selecting the guide strand from small RNA duplexes is different among Argonaute proteins. Plant and Cell Physiology 2008 49 4 493 500 2-s2.0-44349094874 10.1093/pcp/pcn043
56. Carthew R. W., Sontheimer E. J., Origins and Mechanisms of miRNAs and siRNAs. Cell 2009 136 4 642 655 2-s2.0-60149088848 10.1016/j.cell.2009.01.035
57. Han J., Lee Y., Yeom K.-H., Nam J.-W., Heo I., Rhee J.-K., Sohn S. Y., Cho Y., Zhang B.-T., Kim V. N., Molecular basis for the recognition of primary microRNAs by the drosha-DGCR8 complex. Cell 2006 125 5 887 901 2-s2.0-33744520104 10.1016/j.cell.2006.03.043 (Pubitemid 43810154)
58. Gregory R. I., Shiekhattar R., MicroRNA biogenesis and cancer. Cancer Research 2005 65 9 3509 3512 2-s2.0-18144365478 10.1158/0008-5472.CAN-05-0298 (Pubitemid 40616320)
59. Valencia-Sanchez M. A., Liu J., Hannon G. J., Parker R., Control of translation and mRNA degradation by miRNAs and siRNAs. Genes and Development 2006 20 5 515 524 2-s2.0-33644768174 10.1101/gad.1399806 (Pubitemid 43345317)
60. Vasudevan S., Tong Y., Steitz J. A., Switching from repression to activation: microRNAs can up-regulate translation. Science 2007 318 5858 1931 1934 2-s2.0-36749026906 10.1126/science.1149460
61. Ørom U. A., Nielsen F. C., Lund A. H., MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Molecular Cell 2008 30 4 460 471 2-s2.0-43449090367 10.1016/j.molcel.2008.05.001 (Pubitemid 351672378)
62. Tay Y., Zhang J., Thomson A. M., Lim B., Rigoutsos I., MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008 455 7216 1124 1128 2-s2.0-54549108798 10.1038/nature07299
63. Liu J., Control of protein synthesis and mRNA degradation by microRNAs. Current Opinion in Cell Biology 2008 20 2 214 221 2-s2.0-41549110185 10.1016/j.ceb.2008.01.006
64. Friedman R. C., Farh K. K.-H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
65. Grimson A., Farh K. K.-H., Johnston W. K., Garrett-Engele P., Lim L. P., Bartel D. P., MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular Cell 2007 27 1 91 105 2-s2.0-34250805982 10.1016/j.molcel.2007.06.017 (Pubitemid 46991392)
66. Baek D., Villén J., Shin C., Camargo F. D., Gygi S. P., Bartel D. P., The impact of microRNAs on protein output. Nature 2008 455 7209 64 71 2-s2.0-49949116902 10.1038/nature07242
67. Ebert M. S., Sharp P. A., Roles for MicroRNAs in conferring robustness to biological processes. Cell 2012 149 3 505 524 2-s2.0-84860324470 10.1016/j.cell.2012.04.005
68. Földes-Papp Z., König K., Studier H., Bückle R., Breunig H. G., Uchugonova A., Kostner G. M., Trafficking of mature miRNA-122 into the nucleus of live liver cells. Current Pharmaceutical Biotechnology 2009 10 6 569 578 2-s2.0-71749092706 10.2174/138920109789069332
69. Park C. W., Zeng Y., Zhang X., Subramanian S., Steer C. J., Mature microRNAs identified in highly purified nuclei from HCT116 colon cancer cells. RNA Biology 2010 7 5 606 614 2-s2.0-78649357109 10.4161.rna.7.5.13215
70. Taft R. J., Simons C., Nahkuri S., Oey H., Korbie D. J., Mercer T. R., Holst J., Ritchie W., Wong J. J.-L., Rasko J. E. J., Rokhsar D. S., Degnan B. M., Mattick J. S., Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nature Structural and Molecular Biology 2010 17 8 1030 1034 2-s2.0-77955419755 10.1038/nsmb.1841
71. Bonauer A., Boon R. A., Dimmeler S., Vascular microRNAs. Current Drug Targets 2010 11 8 943 949 2-s2.0-77955059181 10.2174/138945010791591313
72. Tufekci K. U., Oner M. G., Genc S., Genc K., MicroRNAs and multiple sclerosis. Autoimmune Disease 2011 2011 1 27
73. Kanwar J. R., Mahidhara G., MicroRNA in human cancer and chronic inflammatory diseases. Frontiers in Bioscience 2010 2 1113 1126 2-s2.0-77956644503
74. Gascon E., Gao F. B., Cause or effect: misregulation ofmicroRNA pathways in neurodegeneration. Frontiers in Neuroscience 2012 6, article 48
75. Thum T., MicroRNA therapeutics in cardiovascular medicine. EMBO Molecular Medicine 2012 4 1 3 14 2-s2.0-84855244103 10.1002/emmm.201100191
76. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
77. O'Connell R. M., Rao D. S., Chaudhuri A. A., Baltimore D., Physiological and pathological roles for microRNAs in the immune system. Nature Reviews Immunology 2010 10 2 111 122 2-s2.0-75649139134 10.1038/nri2708
78. Anglicheau D., Muthukumar T., Suthanthiran M., MicroRNAs: small RNAs with big effects. Transplantation 2010 90 2 105 112 2-s2.0-77954958456 10.1097/TP.0b013e3181e913c2
79. Wiesen J. L., Tomasi T. B., Dicer is regulated by cellular stresses and interferons. Molecular Immunology 2009 46 6 1222 1228 2-s2.0-60949102130 10.1016/j.molimm.2008.11.012
80. Iborra M., Bernuzzi F., Invernizzi P., Danese S., MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmunity Reviews 2012 11 5 305 314 2-s2.0-84857506097 10.1016/j.autrev.2010.07.002
81. Haasch D., Chen Y.-W., Reilly R. M., Grace Chiou X., Koterski S., Smith M. L., Kroeger P., McWeeny K., Halbert D. N., Mollison K. W., Djuric S. W., Trevillyan J. M., T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cellular Immunology 2002 217 1-2 78 86 2-s2.0-18744416255 10.1016/S0008-8749(02)00506-3 (Pubitemid 35352162)
82. Jindra P. T., Bagley J., Godwin J. G., Iacomini J., Costimulation- dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. Journal of Immunology 2010 185 2 990 997 2-s2.0-77955508072 10.4049/jimmunol.1000793
83. Rodriguez A., Vigorito E., Clare S., Warren M. V., Couttet P., Soond D. R., Van Dongen S., Grocock R. J., Das P. P., Miska E. A., Vetrie D., Okkenhaug K., Enright A. J., Dougan G., Turner M., Bradley A., Requirement of bic/microRNA-155 for normal immune function. Science 2007 316 5824 608 611 2-s2.0-34247584465 10.1126/science.1139253 (Pubitemid 46683148)
84. Thai T.-H., Calado D. P., Casola S., Ansel K. M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J. L., Schmidt-Supprian M., Rajewsky N., Yancopoulos G., Rao A., Rajewsky K., Regulation of the germinal center response by MicroRNA-155. Science 2007 316 5824 604 608 2-s2.0-34247594818 10.1126/science.1141229 (Pubitemid 46683147)
85. Vigorito E., Perks K. L., Abreu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., Das P. P., Miska E. A., Rodriguez A., Bradley A., Smith K. G. C., Rada C., Enright A. J., Toellner K.-M., MacLennan I. C. M., Turner M., microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007 27 6 847 859 2-s2.0-37049002638 10.1016/j.immuni.2007.10. 009 (Pubitemid 350258623)
86. Cox M. B., Cairns M. J., Gandhi K. S., Carroll A. P., Moscovis S., Stewart G. J., Broadley S., Scott R. J., Booth D. R., Lechner-Scott J., MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS ONE 2010 5 8 2-s2.0-77957888270 10.1371/journal.pone.0012132 e12132
87. Stittrich A.-B., Haftmann C., Sgouroudis E., Kühl A. A., Hegazy A. N., Panse I., Riedel R., Flossdorf M., Dong J., Fuhrmann F., Heinz G. A., Fang Z., Li N., Bissels U., Hatam F., Jahn A., Hammoud B., Matz M., Schulze F.-M., Baumgrass R., Bosio A., Mollenkopf H.-J., Grün J., Thiel A., Chen W., Höfer T., Loddenkemper C., Löhning M., Chang H.-D., Rajewsky N., Radbruch A., Mashreghi M.-F., The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nature Immunology 2010 11 11 1057 1062 2-s2.0-77958149675 10.1038/ni.1945
88. Monticelli S., Ansel K. M., Xiao C., Socci N. D., Krichevsky A. M., Thai T.-H., Rajewsky N., Marks D. S., Sander C., Rajewsky K., Rao A., Kosik K. S., MicroRNA profiling of the murine hematopoietic system. Genome Biology 2005 6 8 R71 2-s2.0-24644489402
89. Sonkoly E., Pivarcsi A., MicroRNAs in inflammation. International Reviews of Immunology 2009 28 6 535 561 2-s2.0-71449107946 10.3109/08830180903208303
90. Murphy K. M., Reiner S. L., The lineage decisions of helper T cells. Nature Reviews Immunology 2002 2 12 933 944 2-s2.0-0036885067 10.1038/nri954 (Pubitemid 37323214)
91. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., Li Z., Wu Z., Pei G., MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nature Immunology 2009 10 12 1252 1259 2-s2.0-70449716915 10.1038/ni.1798
92. Mycko M. P., Cichalewska M., Machlanska A., Cwiklinska H., Mariasiewicz M., Selmaj K., MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proceedings of the National Academy of Sciences of the United States 2012 109 20 E1248 E1257
93. Mai J., Virtue A., MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors. Frontiers in Bioscience 2012 4 1478 1495
94. O'Connell R. M., Kahn D., Gibson W. S. J., Round J. L., Scholz R. L., Chaudhuri A. A., Kahn M. E., Rao D. S., Baltimore D., MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010 33 4 607 619 2-s2.0-77958495102 10.1016/j.immuni.2010.09.009
95. + T-cell activation, migration, and survival. Proceedings of the National Academy of Sciences of the United States of America 2010 107 50 21629 21634 2-s2.0-78650754295 10.1073/pnas.1016299107
96. Kohlhaas S., Garden O. A., Scudamore C., Turner M., Okkenhaug K., Vigorito E., Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells1. Journal of Immunology 2009 182 5 2578 2582 2-s2.0-64849100152 10.4049/jimmunol.0803162
97. Zhou L., Park J.-J., Zheng Q., Dong Z., Mi Q., MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function. Cellular and Molecular Immunology 2011 8 5 380 387 2-s2.0-80052511814 10.1038/cmi.2011.27
98. Lu L.-F., Boldin M. P., Chaudhry A., Lin L.-L., Taganov K. D., Hanada T., Yoshimura A., Baltimore D., Rudensky A. Y., Function of miR-146a in controlling treg cell-mediated regulation of Th1 responses. Cell 2010 142 6 914 929 2-s2.0-77956632634 10.1016/j.cell.2010.08.012
99. Rouas R., Fayyad-Kazan H., El Zien N., Lewalle P., Rothé F., Simion A., Akl H., Mourtada M., El Rifai M., Burny A., Romero P., Martiat P., Badran B., Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. European Journal of Immunology 2009 39 6 1608 1618 2-s2.0-67649528173 10.1002/eji.200838509
100. + TREG cells by targeting AC9 mRNA. EMBO Reports 2009 10 2 180 185 2-s2.0-59649119933 10.1038/embor.2008.224
101. Chen C.-Z., Li L., Lodish H. F., Bartel D. P., MicroRNAs modulate hematopoietic lineage differentiation. Science 2004 303 5654 83 86 2-s2.0-0346727524 10.1126/science.1091903 (Pubitemid 38055775)
102. Koralov S. B., Muljo S. A., Galler G. R., Krek A., Chakraborty T., Kanellopoulou C., Jensen K., Cobb B. S., Merkenschlager M., Rajewsky N., Rajewsky K., Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008 132 5 860 874 2-s2.0-39749101294 10.1016/j.cell.2008.02.020 (Pubitemid 351312808)
103. Ventura A., Young A. G., Winslow M. M., Lintault L., Meissner A., Erkeland S. J., Newman J., Bronson R. T., Crowley D., Stone J. R., Jaenisch R., Sharp P. A., Jacks T., Targeted deletion reveals essential and overlapping functions of the miR-17 92 family of miRNA clusters. Cell 2008 132 5 875 886 2-s2.0-39749143354 10.1016/j.cell.2008.02.019 (Pubitemid 351312807)
104. Zhou B., Wang S., Mayr C., Bartel D. P., Lodish H. F., miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences of the United States of America 2007 104 17 7080 7085 2-s2.0-56649100636 (Pubitemid 47186012)
105. Xiao C., Calado D. P., Galler G., Thai T.-H., Patterson H. C., Wang J., Rajewsky N., Bender T. P., Rajewsky K., MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007 131 1 146 159 2-s2.0-34547941361 10.1016/j.cell.2007.07.021 (Pubitemid 47498525)
106. Dorsett Y., McBride K. M., Jankovic M., Gazumyan A., Thai T.-H., Robbiani D. F., Di Virgilio M., San-Martin B. R., Heidkamp G., Schwickert T. A., Eisenreich T., Rajewsky K., Nussenzweig M. C., MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008 28 5 630 638 2-s2.0-43049173617 10.1016/j.immuni.2008.04.002
107. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., Papavasiliou F. N., MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008 28 5 621 629 2-s2.0-43049178852 10.1016/j.immuni.2008.03.015
108. de Yébenes V. G., Belver L., Pisano D. G., González S., Villasante A., Croce C., He L., Ramiro A. R., miR-181b negatively regulates activation-induced cytidine deaminase in B cells. Journal of Experimental Medicine 2008 205 10 2199 2206 2-s2.0-53349129731 10.1084/jem.20080579
109. Johnnidis J. B., Harris M. H., Wheeler R. T., Stehling-Sun S., Lam M. H., Kirak O., Brummelkamp T. R., Fleming M. D., Camargo F. D., Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008 451 7182 1125 1129 2-s2.0-39849096995 10.1038/nature06607 (Pubitemid 351317447)
110. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M. L., Nervi C., Bozzoni I., A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBP α regulates human granulopoiesis. Cell 2005 123 5 819 831 2-s2.0-28344438648 10.1016/j.cell.2005.09.023 (Pubitemid 41721029)
111. Li T., Morgan M. J., Choksi S., Zhang Y., Kim Y.-S., Liu Z.-G., MicroRNAs modulate the noncanonical transcription factor NF- B pathway by regulating expression of the kinase IKK α during macrophage differentiation. Nature Immunology 2010 11 9 799 805 2-s2.0-77955924350 10.1038/ni.1918
112. Bazzoni F., Rossato M., Fabbri M., Gaudiosi D., Mirolo M., Mori L., Tamassia N., Mantovani A., Cassatella M. A., Locati M., Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proceedings of the National Academy of Sciences of the United States of America 2009 106 13 5282 5287 2-s2.0-65249131826 10.1073/pnas.0810909106
113. Iyer A., Zurolo E., Prabowo A., MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS ONE 2012 7 9 e44789
114. Lukiw W. J., Zhao Y., Jian G. C., An NF- B-sensitive micro RNA-146a-mediated inflammatory circuit in alzheimer disease and in stressed human brain cells. Journal of Biological Chemistry 2008 283 46 31315 31322 2-s2.0-57649119790 10.1074/jbc.M805371200
115. Wang L.-L., Huang Y., Wang G., Chen S.-D., The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target? Medical Hypotheses 2012 78 3 398 401 2-s2.0-84856450535 10.1016/j.mehy.2011.11.019
116. Ponomarev E. D., Veremeyko T., Barteneva N., Krichevsky A. M., Weiner H. L., MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP- α -PU.1 pathway. Nature Medicine 2011 17 1 64 70 2-s2.0-78651247933 10.1038/nm.2266
117. Celada A., Borràs F. E., Soler C., Lloberas J., Klemsz M., Van Beveren C., McKercher S., Maki R. A., The transcription factor PU.1 is involved in macrophage proliferation. Journal of Experimental Medicine 1996 184 1 61 69 2-s2.0-0030057122 10.1084/jem.184.1.61 (Pubitemid 26247215)
118. Cardoso A. L., Guedes J. R., Pereira de Almeida L., Pedroso de Lima M. C., miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 2012 135 1 73 88 2-s2.0-83055176904 10.1111/j.1365-2567.2011.03514.x
119. Junker A., Krumbholz M., Eisele S., Mohan H., Augstein F., Bittner R., Lassmann H., Wekerle H., Hohlfeld R., Meinl E., MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009 132 12 3342 3352 2-s2.0-72649095061 10.1093/brain/awp300
120. Tarassishin L., Loudig O., Bauman A., Shafit-Zagardo B., Suh H.-S., Lee S. C., Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155. GLIA 2011 59 12 1911 1922 2-s2.0-80053576812 10.1002/glia.21233
121. Fontana L., Pelosi E., Greco P., Racanicchi S., Testa U., Liuzzi F., Croce C. M., Brunetti E., Grignani F., Peschle C., MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nature Cell Biology 2007 9 7 775 787 2-s2.0-34347383305 10.1038/ncb1613 (Pubitemid 47019464)
122. Rosa A., Ballarino M., Sorrentino A., Sthandier O., De Angelis F. G., Marchioni M., Masella B., Guarini A., Fatica A., Peschle C., Bozzoni I., The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proceedings of the National Academy of Sciences of the United States of America 2007 104 50 19849 19854 2-s2.0-38049146022 10.1073/pnas.0706963104
123. Koning N., Bö L., Hoek R. M., Huitinga I., Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Annals of Neurology 2007 62 5 504 514 2-s2.0-37349018717 10.1002/ana.21220 (Pubitemid 350308775)
124. Oldenborg P.-A., Gresham H. D., Lindberg F. P., CD47-signal regulatory protein α (SIRP α) regulates Fc γ and complement receptor-mediated phagocytosis. Journal of Experimental Medicine 2001 193 7 855 861 2-s2.0-0035794312 10.1084/jem.193.7.855 (Pubitemid 32524535)
125. Ceppi M., Pereira A. M., Dunand-Sauthier I., Barras E., Reith W., Santos M. A., Pierre P., MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2009 106 8 2735 2740 2-s2.0-62449173209 10.1073/pnas.0811073106
126. Hashimi S. T., Fulcher J. A., Chang M. H., Gov L., Wang S., Lee B., MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009 114 2 404 414 2-s2.0-67651098994 10.1182/blood-2008-09-179150
127. Bird A., Perceptions of epigenetics. Nature 2007 447 7143 396 398 2-s2.0-34249337761 10.1038/nature05913 (Pubitemid 46816744)
128. Goodnow C. C., Sprent J., De St. Groth B. F., Vinuesa C. G., Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005 435 7042 590 597 2-s2.0-20444485767 10.1038/nature03724 (Pubitemid 40825498)
129. Li Q.-J., Chau J., Ebert P. J. R., Sylvester G., Min H., Liu G., Braich R., Manoharan M., Soutschek J., Skare P., Klein L. O., Davis M. M., Chen C.-Z., MiR-181a is an intrinsic modulator of T Cell sensitivity and selection. Cell 2007 129 1 147 161 2-s2.0-33947721625 10.1016/j.cell.2007.03.008 (Pubitemid 46507589)
130. Zhu D. Y., Liu S. H., Sun H. S., Lu Y. M., Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. Journal of Neuroscience 2003 23 1 223 229 2-s2.0-0037222287 (Pubitemid 36050422)
131. Li L., Li Y., Ji X., Zhang B., Wei H., Luo Y., The effects of retinoic acid on the expression of neurogranin after experimental cerebral ischemia. Brain Research 2008 1226 234 240 2-s2.0-49049092989 10.1016/j.brainres.2008.06. 037
132. Kawano S., Nakamachi Y., MiR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2011 70 supplement 1 188 191 2-s2.0-79952994992 10.1136/ard.2010.138669
133. Arner E., Mejhert N., Kulyte A., Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 2012 61 8 1986 1993
134. Liu J., Liu Y., Zhang H., Chen G., Wang K., Xiao X., KLF4 promotes the expression, translocation, and release of HMGB1 in RAW264.7 macrophages in response to LPS. Shock 2008 30 3 260 266 2-s2.0-52649086692 10.1097/SHK. 0b013e318162bef7
135. Czapski G. A., Cakala M., Chalimoniuk M., Gajkowska B., Strosznajder J.
136. Sonkoly E., Wei T., Janson P. C. J., Sääf A., Lundeberg L., Tengvall-Linder M., Norstedt G., Alenius H., Homey B., Scheynius A., Ståhle M., Pivarcsi A., MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PloS ONE 2007 2 7 e610 2-s2.0-77951233965
137. Condorelli G., Dimmeler S., MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis. Cardiovascular Research 2008 79 4 551 552 2-s2.0-52449131190 10.1093/cvr/cvn189
138. Wang K., Zhang S., Weber J., Baxter D., Galas D. J., Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research 2010 38 20 7248 7259 2-s2.0-78149409316 10.1093/nar/gkq601
139. Arroyo J. D., Chevillet J. R., Kroh E. M., Ruf I. K., Pritchard C. C., Gibson D. F., Mitchell P. S., Bennett C. F., Pogosova-Agadjanyan E. L., Stirewalt D. L., Tait J. F., Tewari M., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America 2011 108 12 5003 5008 2-s2.0-79953202200 10.1073/pnas.1019055108